Among SF3B1-mutated patients, the acquisition of a myeloproliferative phenotype (often characterized by progressive thrombocytosis) has been induced by the simultaneous presence of JAK/STAT pathway mutations. Here, SF3B1 is linked to thrombocytosis disease.